Back To Search Results

Body Surface Area

Editor: Carrie A. Hall Updated: 2/6/2025 1:52:42 AM

Definition/Introduction

Body surface area (BSA) was first used in the late 19th century when the German physiologist Karl M. Meeh formulated the first BSA formula.[1] Meeh's weight-based formula (BSA = 12.312 x weight2/3) was initially derived for animals and later adapted to humans. However, the formula inaccurately reflected the complex relationship between body size and physiological processes.[2] The Du Bois and Du Bois formula was later developed by the American physician Eugene Floyd Du Bois and his wife and collaborator, Delafield Du Bois, to address this limitation. The new formula incorporated height as a variable. Initially devised to quantify metabolic rate and heat loss—key physiological parameters under investigation at the time—the Du Bois formula has since become a cornerstone in medical practice. Over the past century, the quest for precise BSA estimation has created more than 40 mathematical formulas, each based on different state variables.

BSA is widely used for modulating pharmacological therapies, particularly in determining dosages for chemotherapy agents and certain antibiotics, where accurate dosing is critical to maximizing efficacy and minimizing toxicity. Additionally, BSA is used to calculate the cardiac index, estimate body fat percentage, and index various physiological measurements, such as the estimated glomerular filtration rate (eGFR), using equations like the Cockcroft-Gault or Modification of Diet in Renal Disease. 

The Du Bois and Du Bois formula is written as follows: BSA = 0.007184 x (height in cm)0.725 x (weight in kg)0.425 [3]

This formula remains widely used today, though it also has limitations. For instance, this equation may overestimate BSA in individuals with obesity due to their altered body composition compared to the reference population used to derive the formula. Similarly, the Du Bois formula may not be accurate for children with body proportions that differ significantly from adults. In these cases, alternative formulas, such as the Mosteller [BSA = √(height in cm) x (weight in kg) / 3600] and the Haycock [BSA = 0.024265 x (height in cm)0.3964 x (weight in kg)0.5378] formulas, which are specifically designed for children, may be more appropriate.[4][5] Despite the widespread use of the concept, the ongoing debate about BSA's relevance in an era of personalized medicine and advanced measurement techniques warrants consideration.

Issues of Concern

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Issues of Concern

A significant challenge in clinical practice is the variability in BSA calculation due to the numerous available formulas, which can yield substantially different results with potential implications for patient care. This variability is particularly concerning in drug dosing, where precise BSA-based calculations are essential to maintaining therapeutic efficacy while minimizing toxicity. Studies have demonstrated that BSA values can vary by as much as 0.5 m2 for the standard adult physique, depending on the formula used. Such discrepancies can lead to significant variations in the dosages of critical medications, such as methotrexate, doxorubicin, and vancomycin, with potentially serious consequences, including myelosuppression, cardiotoxicity, and nephrotoxicity.[6]

The implications of BSA variability extend beyond pharmacology. For instance, an accurate BSA is essential in burn care to estimate the total BSA affected by burns, which directly informs fluid resuscitation protocols. An overestimation of BSA can result in excessive fluid administration, leading to complications such as pulmonary edema, while underestimation can result in inadequate resuscitation and organ hypoperfusion. In cardiac care, BSA is used to calculate the cardiac index, a critical parameter for evaluating cardiac function. Variations in BSA estimation can significantly influence the interpretation of cardiac index values, potentially leading to misdiagnosis or inappropriate therapeutic interventions.

Given these challenges, careful selection and consistent use of a validated BSA formula are paramount in clinical practice. Clinicians must also be mindful of patient-specific factors, such as obesity, pediatric status, and altered body composition, which may require alternative formulas. Additionally, efforts to standardize BSA calculation methods in clinical guidelines and multicenter studies can help mitigate variability and enhance the reliability of BSA-based assessments in patient care.

Clinical Significance

BSA is a key metric in medicine that is widely used to guide drug dosing, assess disease severity, and calculate physiological parameters. BSA plays an especially crucial role in the areas discussed below.

Pharmacology

BSA is essential for determining dosages for chemotherapeutic drugs, with research showing that BSA-based dosing offers more consistent therapeutic outcomes than dosing based on weight alone.[7] Measuring BSA also guides the administration of certain medications in pediatrics, oncology, and endocrinology (eg, thyroxine replacement), as well as fluid resuscitation in patients with burns using the Parkland formula.[8] BSA is also used to adjust doses for renal impairment and topical medications.

Many antivirals, antimicrobials, and antifungals are dosed based on BSA.[9][10] This approach is preferred for drugs that accumulate in extracellular fluid, as BSA is believed to provide a more accurate representation of extracellular fluid volume and total body water compared to body weight alone.

Assessment of Disease Severity

BSA is critical for estimating the extent of burn injuries, stratifying severity, and guiding resuscitation efforts.[11] BSA also helps evaluate skin diseases such as psoriasis and toxic epidermal necrolysis, determine lymphedema staging, and classify obesity.[12][13][14][15]

Physiological Monitoring and Prognostication

In cardiology, BSA calculates the cardiac index, a measure of cardiac function based on cardiac output and BSA.[16] BSA also plays a role in staging chronic kidney disease, assessing nutritional status, monitoring child growth, and predicting surgical or infection-related outcomes.

Research and Clinical Trials

BSA standardizes data across populations, enabling accurate comparisons in pharmacokinetics, drug toxicity studies, and clinical trials. Using accurate BSA values ensures consistency in research methodology.

Specialized Applications

BSA is indispensable in radiation therapy planning, extracorporeal membrane oxygenation calculations, metabolic rate estimation, and organ transplant sizing.[17] In sports medicine, BSA helps assess drug distribution volumes and body composition for performance evaluations.

Nursing, Allied Health, and Interprofessional Team Interventions

Ensuring Accurate Body Surface Area Calculations in Clinical Practice

Accurately calculating BSA is essential for ensuring safe and effective patient care, particularly in oncology and burn management. Errors in BSA estimation can lead to suboptimal drug dosing, treatment failure, increased toxicity, or severe side effects. To address these risks, healthcare institutions should adopt the strategies listed below.

Oncology

Precise dosing is critical during chemotherapy administration, and clinical teams must be well-versed in BSA calculation methods and their implications. Key recommendations include the following:

  • Standardization of BSA formulas: A validated BSA formula should be selected and consistently used within the institution to minimize variability and confusion.
  • Provision of comprehensive training: BSA calculation should be included in the training and competency assessment of oncologists, pharmacists, and chemotherapy nurses, ensuring proficiency across the team.
  • Utilization of technology: Electronic BSA calculators should be employed, and clinical decision support systems should be integrated to enhance accuracy and streamline workflows.
  • Implementation of double-checking procedures: Mandatory independent verification of BSA calculations by another qualified healthcare professional should be introduced. This measure is especially important when administering high-risk medications.

Burn care

BSA is critical in fluid resuscitation and wound management in burn units. Inaccurate estimates can lead to serious complications, such as inadequate resuscitation, resulting in organ hypoperfusion, or excessive resuscitation, leading to pulmonary edema. Recommendations for burn care teams include the following:

  • Training and competency: Burn surgeons, critical care nurses, and pharmacists should receive comprehensive training in BSA calculation and its clinical applications.
  • Standardized assessment: Validated methods and tools, such as burn-specific BSA charts (eg, the Lund-Browder chart) or electronic systems, should be used for accurate and consistent evaluations.
  • Integration of guidelines: Established guidelines, such as the Parkland formula for fluid resuscitation, should be followed to align BSA calculations with evidence-based practice.

Advancing Professional Knowledge

To further improve patient safety, healthcare professionals are encouraged to pursue continuing education opportunities on BSA calculation and its applications in clinical care. Regular updates on best practices can help maintain high standards in patient management. Institutions can enhance treatment outcomes and improve patient safety in oncology and burn care by prioritizing accurate BSA calculations and equipping healthcare professionals with the necessary knowledge, tools, and systems.

The Artec 3D Eva (Artec 3D, Senningerberg, Luxembourg) handheld scanner was recently developed to calculate the BSA precisely.[18] This device offers an accurate and reliable alternative to traditional estimation methods, and its use should be considered in healthcare facilities. In recent years, increasing interest has focused on utilizing BSA to investigate the obesity paradox in chronic diseases. Research suggests a link between lower BSA values and worse prognoses in patients with heart failure, acute kidney injury, and peripheral artery disease.[19]

Nursing, Allied Health, and Interprofessional Team Monitoring

BSA calculation is a fundamental tool in clinical practice, with crucial applications in oncology, burn care, and critical care. Accurate calculations ensure safe and effective treatments, particularly in guiding drug dosing and assessing burn severity. Healthcare professionals must use standardized formulas, validated tools, and evidence-based protocols to minimize errors. Incorporating BSA training into clinical education and fostering ongoing professional development further enhance its accurate use in practice. In summary, accurate BSA calculation is more than a technical requirement. This approach is vital to patient safety and high-quality care.

References


[1]

Redlarski G, Palkowski A, Krawczuk M. Body surface area formulae: an alarming ambiguity. Scientific reports. 2016 Jun 21:6():27966. doi: 10.1038/srep27966. Epub 2016 Jun 21     [PubMed PMID: 27323883]


[2]

Gibson S, Numa A. The importance of metabolic rate and the folly of body surface area calculations. Anaesthesia. 2003 Jan:58(1):50-5     [PubMed PMID: 12523324]


[3]

Burton RF. Estimating body surface area from mass and height: theory and the formula of Du Bois and Du Bois. Annals of human biology. 2008 Mar-Apr:35(2):170-84. doi: 10.1080/03014460801908439. Epub     [PubMed PMID: 18428011]


[4]

Mosteller RD. Simplified calculation of body-surface area. The New England journal of medicine. 1987 Oct 22:317(17):1098     [PubMed PMID: 3657876]


[5]

Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. The Journal of pediatrics. 1978 Jul:93(1):62-6     [PubMed PMID: 650346]


[6]

Sigurdsson TS, Lindberg L. Six commonly used empirical body surface area formulas disagreed in young children undergoing corrective heart surgery. Acta paediatrica (Oslo, Norway : 1992). 2020 Sep:109(9):1838-1846. doi: 10.1111/apa.15208. Epub 2020 Feb 17     [PubMed PMID: 32010999]


[7]

Kaestner SA, Sewell GJ. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clinical oncology (Royal College of Radiologists (Great Britain)). 2007 Feb:19(1):23-37     [PubMed PMID: 17305252]


[8]

Cuijpers MD, Akkerman M, Baartmans MGA, van Zuijlen PPM, Pijpe A. The Early Childhood Development of Pediatric Burn Patients. European burn journal. 2024 May 14:5(2):145-154. doi: 10.3390/ebj5020012. Epub 2024 May 14     [PubMed PMID: 39599984]


[9]

Vaudry W, Ettenger R, Jara P, Varela-Fascinetto G, Bouw MR, Ives J, Walker R, Valcyte WV16726 Study Group. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009 Mar:9(3):636-43. doi: 10.1111/j.1600-6143.2008.02528.x. Epub     [PubMed PMID: 19260840]


[10]

Pai MP. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pharmacotherapy. 2012 Sep:32(9):856-68. doi: 10.1002/j.1875-9114.2012.01108.x. Epub 2012 Jun 18     [PubMed PMID: 22711238]


[11]

Retrouvey H, Chan J, Shahrokhi S. Comparison of two-dimensional methods versus three-dimensional scanning systems in the assessment of total body surface area estimation in burn patients. Burns : journal of the International Society for Burn Injuries. 2018 Feb:44(1):195-200. doi: 10.1016/j.burns.2017.07.003. Epub 2017 Aug 7     [PubMed PMID: 28797577]


[12]

Zhou Y, Chen W, Fang L, Qiu F, Wu J, Li J. Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study. Frontiers in medicine. 2024:11():1473356. doi: 10.3389/fmed.2024.1473356. Epub 2024 Nov 14     [PubMed PMID: 39610686]

Level 2 (mid-level) evidence

[13]

Nazerian A, Jafarzadeh A, Salehi S, Ghasemi M, Goodarzi A. Cyclosporin for the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): a systematic review of observational studies and clinical trials focusing on single therapy, combination therapy, and comparative assessments. Inflammopharmacology. 2024 Oct 29:():. doi: 10.1007/s10787-024-01590-0. Epub 2024 Oct 29     [PubMed PMID: 39470865]

Level 1 (high-level) evidence

[14]

Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian journal of cancer. 2004 Jan-Mar:41(1):8-12     [PubMed PMID: 15105573]


[15]

He Q, Sun H, Li F, Liang N. Obesity and risk of differentiated thyroid cancer: A large-scale case-control study. Clinical endocrinology. 2019 Dec:91(6):869-878. doi: 10.1111/cen.14091. Epub 2019 Oct 1     [PubMed PMID: 31479527]

Level 2 (mid-level) evidence

[16]

Patel N, Durland J, Awosika AO, Makaryus AN. Physiology, Cardiac Index. StatPearls. 2025 Jan:():     [PubMed PMID: 30969727]


[17]

Okada N, Murayama H, Hasegawa H, Kawai S, Mori H, Yasuda K. Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Decision for Pediatric Fulminant Myocarditis. Artificial organs. 2016 Aug:40(8):793-8. doi: 10.1111/aor.12673. Epub 2016 Jan 27     [PubMed PMID: 26833577]


[18]

Redlarski G, Kozieł S, Krawczuk M, Siebert J, Tałałaj M, Pałkowski A, Tojza P, Cieślikowska Z, Litzbarski LS. An improvement of body surface area formulas using the 3D scanning technique. International journal of occupational medicine and environmental health. 2024 May 20:37(2):205-219. doi: 10.13075/ijomeh.1896.02356. Epub 2024 Apr 16     [PubMed PMID: 38634421]


[19]

Piecuch M, Chylak M, Górski M, Garbicz-Kata J, Szczyrba A, Buczkowska M, Malinowska-Borowska J, Nowak JU, Niedziela JT, Gąsior M, Rozentryt P. Comparison of the Effectiveness of Body Surface Area Estimation Formulas in Predicting the Risk of Death in Patients with Heart Failure. Journal of clinical medicine. 2024 Nov 4:13(21):. doi: 10.3390/jcm13216625. Epub 2024 Nov 4     [PubMed PMID: 39518764]